MEASUREMENT OF BLOOD FLOW IN ARTERIA MENINGEA MEDIA OF PATIENTS WITH FREQUENT EPISODIC TENSION-TYPE HEADACHE NOT ASSOCIATED WITH PERICRANIAL TENDERNESS

by A.A. Skoromets, L.G. Zaslavsky, E.P. Evdoshenko
Published 2008-06-01

The effect of cardiovascular diseases on the course of multiple sclerosis (review of literature)

by N. A. Neofidov, N. A. Totolyan, M. V. Shumilina, A. A. Skoromets, E. P. Evdoshenko
Published 2020-02-01

DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF INTRATHECAL SYNTHESIS OF IMMUNOGLOBULIN FREE LIGHT CHAINS IN MULTIPLE SCLEROSIS

by V. D. Nazarov, S. V. Lapin, E. A. Surkova, E. P. Evdoshenko, G. S. Makshakov, Areg A. Totolian
Published 2015-06-01

Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects»

by N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina
Published 2019-12-01

Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody

by A. N. Boyko, N. V. Khachanova, D. S. Korobko, D. S. Kasatkin, Ya. V. Vlasov, E. P. Evdoshenko, E. V. Popova, K. Z. Bakhtiyarova, S. A. Sivertseva
Published 2021-06-01

New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis

by D. S. Kasatkin, N. V. Khachanova, V. M. Alifirova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, M. V. Davydovskaya, E. P. Evdoshenko, S. A. Sivertseva
Published 2021-02-01

OPPORTUNITIES OF ANTI B-CELL THERAPY IN MULTIPLE SCLEROSIS

by E. P. Evdoshenko, A. L. Maslyancky, L. G. Zaslavsky, A. A. Skoromets, I. S. Ziuzgin, O. E. Riabykina, N. A. Totolian, E. E. Zueva, S. V. Lapin, Areg A. Totolian
Published 2014-07-01

COVID-19 vaccination guidelines for patients with multiple sclerosis

by N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, A. P. Prodeus, M. N. Zakharova, N. N. Spirin, A. N. Boyko
Published 2021-04-01

Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis

by A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko
Published 2019-11-01

Diagnostic significance of intrathecally synthesized immunoglobulins against neurotropic viruses (MRZ-reaction) in diagnosis of multiple sclerosis

by A. N. Moshnikova, V. K. Maksimchuk, S. V. Lapin, V. D. Nazarov, E. A. Surkova, S. A. Novikov, G. S. Makshakov, I. Yu. Krutetskaya, V. S. Krasnov, Ya. B. Kushnir, N. A. Neofidov, N. A. Totolian, A. A. Skoromets, E. P. Evdoshenko, Areg A. Totolian
Published 2020-02-01